Six antibodies hold significance in a PCD diagnosis from patients’ serum and CSF: anti-Yo, anti-Hu, anti-Ri, anti-amphiphysin, anti-CV2, and anti-Ma2/TA. This evidence concerns the gene CDR2 and paraneoplastic neurologic syndrome.